Fact Sheet: United States Delivers Breakthrough HIV Prevention Medication to Uganda
April 2026 The United States, in partnership with the Global Fund, has delivered lenacapavir, a cutting-edge new HIV prevention medication developed by U.S. company Gilead, to Uganda—marking a significant milestone in the global fight against HIV/AIDS. Uganda is one of the ten priority countries selected for the initial rollout and the fifth in Africa to…
